CynergisTek Gains Momentum with its New Biomedical Device Security Risk Assessment Service to Improve Cybersecurity
Cybersecurity Firm Signs on Multiple Leading Healthcare Organizations for Service; Sees Increasing Demand to Address Medical Device Security Challenges
Austin, TX – September 11, 2018 – CynergisTek, (NYSE AMERICAN: CTEK), a leader in healthcare cybersecurity and information assurance, today announced it began providing its new Biomedical Device Security Risk Assessment service to multiple health systems, including a large, 28-hospital health system. Offered as the first step of its larger managed BioMedical Device Security service program, the assessment takes an enterprise approach to reviewing healthcare organizations’ security and risk management of biomedical and clinical devices to identify gaps, vulnerabilities, and risks and provides recommendations for improving overall device security.
Biomedical devices are being introduced into hospitals’ networks at a rapid pace, resulting in increased vulnerabilities, new threat vectors, and greater risk to both patient care and patient data. In response to these new risks, CynergisTek launched the Biomedical Device Security Risk Assessment service last spring. With this service, healthcare organizations can take a holistic approach to assessing medical device management to gain an understanding of the number of devices and their known risks and vulnerabilities to develop a more comprehensive security strategy that covers the full lifecycle of devices.
“If a biomedical device is compromised or taken offline by a hacker, that poses a significant safety threat as providers may be unable to deliver the care a patient needs, putting the patient’s life in danger,” said David Finn, Executive Vice President of CynergisTek. “Given the crucial role biomedical devices play in delivering patient care, it is critical that healthcare organizations take proactive steps to address the risks and vulnerabilities associated with these devices.”
“We’ve heard loud and clear from our clients that this is a top concern for them, which prompted us to begin developing a portfolio of biomedical device security services to solve this problem,” said Mac McMillan, CEO at CynergisTek. “As healthcare continues to be a top target for cyberattacks, biomedical devices are an additional entry point into the network for malicious actors. Our services will be specifically tailored to provide an end-to-end approach to device security by identifying, locating, evaluating and mitigating risk across all devices in use at an organization. We have seen high demand for this solution because it is the first that combines technology and process to accurately find and assess these devices without creating additional risk.”
CynergisTek is developing a comprehensive set of managed services to ensure security best practices for the planning, implementation, and ongoing maintenance of an organization’s biomedical device lifecycle management program. From device acquisition to retirement, CynergisTek’s managed service program will provide initial one-time services to support program implementation and optimization activities as well as ongoing support to ensure a continued focus on addressing new biomedical device vulnerabilities and risks as they are discovered.
CynergisTek is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, compliance, and document output goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS in the 2016 and 2018 Cybersecurity reports as a top performing firm in healthcare cybersecurity as well as the 2017 Best in KLAS winner for Cybersecurity Advisory Services.
This release contains certain forward-looking statements relating to the business of CynergisTek that can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “may” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product/service development, long and uncertain sales cycles, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, future capital requirements, competition from other providers, the ability of our vendors to continue supplying the company with equipment, parts, supplies and services at comparable terms and prices and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
CynergisTek Investor Relations Contact:
(617) 332-9999 x241